half year financial report 31 december 2004 contents chairman s 1 directors 5 statement of performance 8 position 9 cash flows 10 notes to the statements 11 declaration 14 independent review members iatia ltd 15 corporate information 16 six months have been a period great change for new strategy now focuses on high value strategic markets and development alliances joint ventures we are also focusing oem sub licensing agreements as well collaborative funded research with transfer upfront costs risks where applicable this has achieved its first worthwhile success integration qpi into ge healthcare automated cell analyser product biopharmaceutical industry in nanotechnology our licensee hrem japan started selling incorporated revenues received targeting defence resulted company being awarded 2 7 million department capability technology demonstrator ctd award
